|

N-Acetylcysteine Clinical Trials

5 actively recruiting trials across 3 locations

No change since May 2026

Also known as: N-AC, NAC, NAC; Acetylcysteine; N-acetyl-cysteine; N-acetyl-L-cysteine

Pipeline

Phase 1: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

  • University of Cincinnati1
  • University of California, Irvine1
  • National University of Malaysia1
  • Michio Hirano, MD1
  • Bioaraba Health Research Institute1

Indications

  • Alcoholic Hepatitis1
  • Mild Depression1
  • Mitochondrial Disease1
  • Liver Disease1
  • MPN1

Other2 trials

Efficacy & Safety of Dry Powder Ivy Extract (Syrup Prospan) Versus NAC Among COPD Patients
N/A
Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)
N/A

Irvine, California1 trial

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

University of California, Irvine

Phase 1/2

New York, New York1 trial

Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels

Columbia University Irving Medical Center

Phase 1

Cincinnati, Ohio1 trial

Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth

University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.